Ibuprofen Pfleger (Ibuprofen D,l-Lysinate)

Ibuprofen D,l-Lysinate inhibits both COX‑1 and COX‑2 enzymes, blocking the synthesis of prostaglandins that mediate pain, fever, and inflammation. By lowering prostaglandin levels, the drug reduces peripheral sensitization of nerves, lowers the hypothalamic temperature set‑point, and diminishes inflammatory exudate.

The appropriate dose of Ibuprofen Pfleger is determined by a qualified prescriber based on the individual’s condition, age, weight, and response to therapy. Patients should follow the prescribing information and never exceed the recommended amount without medical advice.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and clinical circumstances. It is generally avoided in the third trimester and should only be used in pregnancy or while breastfeeding when clearly needed and after consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen Pfleger offers a similar efficacy profile to other non‑selective NSAIDs such as naproxen or diclofenac, but its D,l‑lysinate salt may provide improved gastrointestinal tolerance in some patients. Choice of NSAID often depends on individual risk factors, dosing frequency, and physician preference.

Store Ibuprofen Pfleger at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ibuprofen Pfleger is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce the likelihood of stomach upset. Follow the prescriber’s instructions regarding timing and frequency.

The most serious risks include gastrointestinal bleeding or ulcer perforation, severe renal impairment, and hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience signs of serious bleeding, sudden kidney problems, or severe allergic symptoms.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, or advanced renal disease should avoid Ibuprofen Pfleger. It is also contraindicated in the third trimester of pregnancy and in patients taking certain anticoagulants without close monitoring.